It s actually two leadless pacemakers, one atrial and the other ventricular, linked as if in a wireless network, that together maintained true AV synchronous pacing in a short-term study.
A dual-chamber leadless pacemaker was successfully implanted in most patients and met its 3-month safety and efficacy performance goals, according to the results of the Aveir DR i2i investigational device exemption trial.Single-chamber leadless pacemakers avoid the lead-related complications of transvenous pacemakers, but they do not support atrial pacing or atrioventricular synchrony, so the
/PRNewswire/ Abbott (NYSE: ABT) today announced the world s first patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i™.